J&J’s Vaccine Rollout a Shot in the Arm for These Biotech ETFs
March 02, 2021 at 08:00 AM EST
Biotech ETFs are climbing again on Monday, as the the CDC approved Johnson & Johnson’s coronavirus vaccine for emergency use this past weekend. The Centers for Disease Control and Prevention advisory panel voted unanimously Sunday to recommend the use of Johnson & Johnson’s one-shot...